BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34695521)

  • 1. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
    Taggar AS; Mann P; Folkert MR; Aliakbari S; Myrehaug SD; Dawson LA
    Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
    Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
    World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
    Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
    Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
    Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
    Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
    Shin HS; Seong J; Kim WC; Lee HS; Moon SR; Lee IJ; Lee KK; Park KR; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):105-12. PubMed ID: 12909222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice.
    Xu X; Li J; Wu J; Zhu R; Ji W
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):206-217. PubMed ID: 29075881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the Safety and Efficacy of Intraluminal Brachytherapy vs Isolated Percutaneous Transhepatic Biliary Drainage with internalization for Unresectable Malignant Biliary Obstruction: A Prospective Observational Study.
    Sood S; Alexander JV; Gupta M; Chauhan A
    Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):21-28. PubMed ID: 37581465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
    Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
    Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report.
    Macchia G; Costamagna G; Morganti AG; Mutignani M; Giuliante F; Clemente G; Deodato F; Smaniotto D; Mattiucci GC; Sallustio G; Valentini V; Nuzzo G; Cellini N
    Dig Liver Dis; 2005 Aug; 37(8):615-8. PubMed ID: 15890567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
    Singh V; Kapoor R; Solanki KK; Singh G; Verma GR; Sharma SC
    Liver Int; 2007 Apr; 27(3):347-52. PubMed ID: 17355456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
    Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
    Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.
    Chan SY; Poon RT; Ng KK; Liu CL; Chan RT; Fan ST
    World J Gastroenterol; 2005 May; 11(20):3161-4. PubMed ID: 15918211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraluminal brachytherapy in bile duct carcinomas.
    Leung J; Guiney M; Das R
    Aust N Z J Surg; 1996 Feb; 66(2):74-7. PubMed ID: 8602818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: a propensity-score matched-pair analysis.
    Yoshioka Y; Ogawa K; Oikawa H; Onishi H; Kanesaka N; Tamamoto T; Kosugi T; Hatano K; Kobayashi M; Ito Y; Takayama M; Takemoto M; Karasawa K; Nagakura H; Imai M; Kosaka Y; Yamazaki H; Isohashi F; Nemoto K; Nishimura Y;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):822-9. PubMed ID: 24969796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
    Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
    Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of high-dose-rate intraluminal brachytherapy by percutaneous transhepatic biliary drainage in the palliative management of malignant biliary obstruction--a pilot study.
    Aggarwal R; Patel FD; Kapoor R; Kang M; Kumar P; Chander Sharma S
    Brachytherapy; 2013; 12(2):162-70. PubMed ID: 23186613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.
    Chen Y; Wang XL; Yan ZP; Cheng JM; Wang JH; Gong GQ; Qian S; Luo JJ; Liu QX
    World J Gastroenterol; 2004 Dec; 10(23):3506-10. PubMed ID: 15526374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
    Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
    Leung JT; Kuan R
    Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.